Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06877572 · ClinicalTrials.gov registry record
Weight Loss Management in Endometrial Cancer Survivors
A clinical trial of Weight Management and Endometrial Cancer Survivors, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06877572: Recruiting study of Weight Management and Endometrial Cancer Survivors, sponsored by University of Kansas Medical Center.
NCT06877572 is a study of Weight Management and Endometrial Cancer Survivors that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 50 participants, below the 862-participant average among 8 other Weight Management trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06877572, a study of Weight Management and Endometrial Cancer Survivors, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis. Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options. * If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications. * If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care. The study will also try to understand reasons why patients did or did not start using a weight loss medication.
Primary Outcome
We will track the number of participants who do and do not start medication. Patients will be offered GLP-1 agonist, naltrexone/bupropion, orlistat, or phentermine/topiramate based discussion with weight management specialist.
Conditions Studied
Interventions
- BEHAVIORAL Weight loss with pharmacotherapy
- BEHAVIORAL Weight loss without pharmacotherapy
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-03-25 |
| Est. Completion | 2030-10 |
What NCT06877572 shows while recruiting
NCT06877572 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 862-participant average among 8 other Weight Management trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Weight Management appearing as the primary indexed condition, and to 2 interventions - of which Weight loss with pharmacotherapy is the first listed.
NCT06877572 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06877572 about?
NCT06877572 is a clinical study titled "Weight Loss Management in Endometrial Cancer Survivors". This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage e...
What is the current status of trial NCT06877572?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-03-25. Estimated completion is 2030-10.
What conditions does trial NCT06877572 study?
This clinical trial studies the following conditions: Weight Management, Endometrial Cancer Survivors, Early Stage Endometrial Cancer.
What interventions are being tested in trial NCT06877572?
The interventions under investigation include: Weight loss with pharmacotherapy (BEHAVIORAL), Weight loss without pharmacotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06877572?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06877572 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06877572's enrollment target sits among peer trials
50 5th of 8 higher than 2 of 8 other Weight Management trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Advancing Biopsychosocial Care Training Initiative
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Weight Management After Cancer for Survivors in Rural Communities
RECRUITING · NA
-
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
RECRUITING · Phase 1
-
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
RECRUITING
-
A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI